Blonde L, Belousova L, Fainberg U, Garcia-Hernandez PA, et al. Liraglutide as add-on to SGLT2 inhibitors in patients with inadequately controlled type 2 diabetes: LIRA-ADD2SGLT2i, a 26-week, randomized, double-blind, placebo-controlled trial. Diabetes Obes Metab 2020 Jan 27. doi: 10.1111/dom.13978.
PMID: 31984646